Investor Centre
Summit is publicly listed in the US (NASDAQ)
News
Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
VIEW NEWS
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
VIEW NEWS
Share Price
NASDAQ: SMMT
At 20/01/2021 07:13
Financial Reports
Annual Report and Accounts for Eleven Months Ended 31 December 2019
VIEW REPORT
US 20-F for the Eleven Months Ended 31 December 2019
VIEW REPORT
AIM Delisting FAQs
A set of frequently asked questions about the cancellation to trading of our ordinary shares is available for download.
Analyst Coverage
VisitShareholder Meetings
VisitCorporate Governance
The board believes that good corporate governance is integral to a successful business. We look to apply the highest standards of corporate governance appropriate to a company of our size and development stage, while balancing the need to ensure that the business has the correct level of skills and expertise required to manage a global company and fulfil our regulatory obligations into distinct jurisdictions.